About
I've long been drawn to the immune system's capacity for protection and harm, wondering whether we can tip that balance intentionally.
That question led me from Miami to Chicago to New York, through protein engineering, computational biology, and mouse models, all in pursuit of teaching the immune system to choose tolerance in a targeted manner.
I'm currently a postdoctoral associate at NYU, working with Jeffrey Hubbell on engineering proteins that leverage efferocytic pathways to induce antigen-specific immune tolerance.
Increasingly, I work AI-augmented — building my own computational tools to make the science faster, more reproducible, and less bottlenecked by friction.
Education
Ph.D., Molecular Engineering
University of Chicago, Pritzker School of Molecular Engineering
Advisor: Jeffrey A. Hubbell
Dissertation: Recombinant Fusions of Antigen with Mediators of Efferocytosis Modulate Antigen-Specific Immune Responses
B.S., Biomedical Engineering, Summa Cum Laude
University of Miami
High School
Illinois Mathematics & Science Academy
Technical Expertise
Wet Lab
Computational
Leading the single-cell multiome and spatial-transcriptomics analysis arm of a Colton Center for Autoimmunity grant.
AI-Augmented Workflow
A heavy day-to-day user of Claude Code — not to offload thinking, but to build custom tools that remove friction from my science. I operationalized a released molecular-recognition foundation model into a working HPC pipeline for in-silico protein-interface screening, and stood up computational infrastructure across two campuses.
Research Focus
My research centers on the hypothesis that efferocytosis — the process by which phagocytes clear apoptotic cells — can be leveraged to induce immunological tolerance in a targeted and antigen-specific manner.
By designing proteins that engage efferocytic pathways while presenting specific antigens, we can potentially treat autoimmune diseases and allergies without the broad immunosuppression of current therapies.